Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Regency Capital Partners: The Heat Is On
Grabenwarter, Uli; Mitchell, Jordan; Mayer F.; Liechtenstein, HeinrichCaso F-827-EFinanzasA senior manager at Durable Capital Partners (DCP) must decide between two investments for the company's seventh private equity fund by evaluating each investment memoranda. The first investment calls for DCP to be a junior partner in a syndicated deal. By investing in the first company, DCP's fund would be fully invested and the company could begin to fundraise for its eighth fund. The second investment, is in DCP's ideal range in terms of size ...Desde 8,20 €
-
The Carbon Market
Perold, Andre F.; Reinhardt, Forest L.; Hyman, MikellCaso HBS-209064-EFinanzasThe carbon market has emerged in response to concerns about global climate change. This note characterizes the market in 2008, describing each segment and how it operates.Desde 8,20 €
-
International Carbon Finance and EcoSecurities
Perold, Andre F.; Reinhardt, Forest L.; Hyman, MikellCaso HBS-208151-EFinanzasIn late 2007, EcoSecurities had to decide whether to undertake a new Clean Development Mechanism (CDM) project in China. EcoSecurities was an aggregator of carbon credits and also invested directly in projects that produced carbon credits. Governments andDesde 8,20 €
-
ExQuisit IV European Private Equity Fund: To Invest or Not
Grabenwarter, Uli; Liechtenstein, HeinrichCaso F-826-EFinanzasThis case introduces an in-class analysis of a private placement memorandum (PPM) of a new private equity fund. Students will evaluate the PPM along the following criteria: the fund's investment strategy, past financial performance, expected returns, the size of the fund's targets, the regions and sectors, holding periods, governance issues, the fund's team and benchmark data.Desde 8,20 €
-
Aphrodite Partners versus Cashmine Capital Partners: Regulation Attempts in a Private Industry
Grabenwarter, Uli; Campisi, Sergio; Liechtenstein, HeinrichCaso F-842-EEconomía, FinanzasThis case deals with transparency and disclosure policies of GPs in the interaction with their investor base and serves as a discussion base for the question, whether Fund management activities in Private Equity should be subject to higher scrutiny and/or financial market regulation. The case projects this industry four years into the future, inviting students to suggest possible conclusions from the ongoing debate on higher regulatory oversight...Desde 8,20 €
-
Taurion Inc. - Built to Cure an Incurable Disease (VCs)
Liechtenstein, Heinrich; Grabenwarter, UliCaso F-874-EFinanzas, Iniciativa emprendedoraTaurion Inc. is a start-up company established in 2006 and based in Vienna. It specializes in researching the causes of Alzheimer's disease (AD) as well as developing diagnostic tools and targeted drugs to combat it. For several years, the founders of the company - two renowned scientists and a finance professional - have been focusing on the role of one deficient protein present in the brains of Alzheimer's patients, the tau protein, which is b...Desde 8,20 €
-
Accent Equity Partners and the San Sac Deal
Kolarova, Lenka; Liechtenstein, Heinrich; Grabenwarter, UliCaso F-983-EFinanzas, Iniciativa emprendedoraIt was April 2019, and Niklas Sloutski, Chief Executive Officer of Accent Equity Partners, a Stockholm-based private equity firm, had just returned from a meeting with the firm's partners. The meeting in which they reviewed the firm's investment portfolio brought discussions about the implications of pursuing a possible exit from the investment in the San Sac Group, a market-leading provider of waste sorting, containment and compaction products i...Desde 8,20 €
-
Taurion Inc. - Built to Cure an Incurable Disease (Entrepreneurs)
Ramírez Maz, Daniel; Liechtenstein, Heinrich; Grabenwarter, UliCaso F-873-EFinanzas, Iniciativa emprendedora, Innovación y cambioTaurion Inc. is a start-up company established in 2006 and based in Vienna. It specializes in researching the causes of Alzheimer's disease (AD) as well as developing diagnostic tools and targeted drugs to combat it. For several years, the founders of the company - two renowned scientists and a finance professional - have been focusing on the role of one deficient protein present in the brains of Alzheimer's patients, the tau protein, which is be...Desde 8,20 €